CN Stock MarketDetailed Quotes

300482 Guangzhou Wondfo Biotech

Watchlist
  • 20.03
  • -0.38-1.86%
Market Closed Sep 13 15:00 CST
9.64BMarket Cap18.95P/E (TTM)

Guangzhou Wondfo Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
-62.27%393.56M
56.27%1.17B
-27.72%840.3M
226.30%732.82M
79.15%1.04B
27.88%749M
16.70%1.16B
-75.46%224.58M
-39.37%582.19M
-37.95%585.7M
Transactional financial assets
35.92%1.45B
-21.28%1.01B
-22.99%722.45M
-9.30%1.35B
-19.33%1.06B
150.56%1.28B
63.79%938.07M
269.66%1.49B
109.12%1.32B
36.54%512.32M
Notes receivable and accounts receivable
40.50%826.87M
31.36%744.11M
10.89%599.87M
-10.82%568.8M
-7.21%588.51M
-72.47%566.47M
7.81%540.97M
18.74%637.79M
22.11%634.26M
417.21%2.06B
-Notes receivable
-86.55%391.16K
-90.32%195.22K
104.93%1.65M
-65.86%1.52M
-64.59%2.91M
48.38%2.02M
-76.71%806.42K
-5.69%4.44M
37.67%8.21M
79.14%1.36M
-Accounts receivable
41.13%826.48M
31.79%743.92M
10.75%598.22M
-10.43%567.28M
-6.46%585.6M
-72.55%564.45M
8.40%540.16M
18.96%633.35M
21.93%626.05M
417.86%2.06B
Other receivables (including interest and dividends)
-10.11%70.67M
-31.77%58.76M
-22.35%51.72M
-30.45%75.28M
-1.46%78.62M
3.85%86.12M
2.95%66.6M
-1.57%108.23M
-24.98%79.79M
18.74%82.93M
-Other receivable
-10.11%70.67M
----
-22.35%51.72M
----
-1.46%78.62M
----
2.95%66.6M
----
-24.98%79.79M
----
Contractual assets
----
----
----
----
----
----
----
--0
----
----
Advance payment
-34.38%21.36M
-33.97%26.11M
-35.01%17.26M
-45.89%27.87M
-55.64%32.54M
-68.92%39.55M
-50.40%26.56M
-13.65%51.5M
1.99%73.37M
153.22%127.22M
Inventories
-0.80%412.39M
-25.67%346.89M
-12.14%351.4M
-33.58%381.74M
-33.44%415.73M
-38.46%466.71M
3.55%399.97M
23.04%574.7M
25.44%624.62M
74.24%758.37M
Receivable financing
----
----
----
----
----
----
----
--0
----
----
Assets held for sale
----
----
----
----
----
----
----
--0
----
----
Non-current assets due within one year
----
----
----
----
----
----
--200.26M
--0
----
----
Other current assets
1,812.90%496.33M
2,868.37%693.45M
4,110.41%650.34M
81.39%18.85M
266.22%25.95M
277.53%23.36M
49.12%15.45M
-0.34%10.39M
-17.16%7.08M
-94.15%6.19M
Total current assets
12.90%3.67B
25.99%4.05B
-3.49%3.23B
1.93%3.16B
-2.17%3.25B
-22.17%3.21B
29.58%3.35B
23.74%3.1B
18.79%3.32B
73.69%4.13B
Non Current assets
Debt investment
171.28%569.22M
-47.76%215.91M
-70.31%213.94M
-76.81%211.87M
-76.85%209.83M
-0.07%413.34M
75.01%720.48M
123.00%913.6M
122.35%906.51M
-26.02%413.63M
Other debt investment
----
----
----
----
----
----
----
--0
----
----
Other equity investment
-56.19%89.18M
-55.54%89.18M
-55.46%89.18M
-10.16%203.07M
-9.94%203.57M
-11.27%200.57M
-11.42%200.22M
20.42%226.04M
20.42%226.04M
20.42%226.04M
Other non-current financial assets
----
----
----
----
----
----
----
--0
----
----
Investment real estate
----
----
----
----
----
----
----
--0
----
----
Long-term equity investment
14.41%449.48M
25.05%453.62M
11.79%406.36M
12.65%391.34M
15.90%392.88M
9.08%362.74M
8.94%363.52M
2.24%347.39M
13.82%338.98M
18.00%332.54M
Long term receivable account
----
----
----
----
----
----
----
--0
----
----
Fixed assets
2.28%999.66M
----
5.50%1.02B
----
1.87%977.33M
----
13.16%963.8M
----
72.84%959.38M
----
Constru in process
21.22%359.74M
----
46.05%290.84M
----
221.59%296.76M
----
1,116.01%199.14M
----
-52.31%92.28M
----
Productive biological assets
----
----
----
----
----
----
----
--0
----
----
Oil and gas assets
----
----
----
----
----
----
----
--0
----
----
Intangible assets
-3.66%190.72M
-6.43%188.32M
-4.51%194.52M
-15.99%190.87M
-15.59%197.96M
-20.21%201.26M
-2.11%203.71M
26.24%227.21M
28.99%234.52M
44.75%252.25M
Development expenditure
31.39%70.37M
31.37%65.65M
28.94%66.74M
25.31%69.75M
-2.32%53.55M
-8.53%49.98M
-4.31%51.76M
-35.69%55.66M
-14.75%54.83M
-4.67%54.64M
Goodwill
-3.43%111.42M
-3.43%111.42M
-3.43%111.42M
-27.23%115.37M
-27.23%115.37M
-5.21%115.37M
171.38%115.37M
227.66%158.54M
227.66%158.54M
151.53%121.71M
Long deferred expense
27.79%17.02M
51.81%18.23M
0.12%13.29M
-20.76%12.44M
-14.22%13.32M
-38.38%12.01M
-15.23%13.28M
-0.93%15.7M
7.90%15.53M
33.42%19.48M
Deferred tax assets
25.81%62.61M
4.06%59.93M
6.71%57.47M
-0.84%50.48M
-5.84%49.77M
-5.40%57.59M
25.93%53.86M
19.85%50.91M
102.55%52.85M
100.76%60.88M
Usufruct assets
-6.85%51.86M
177.98%56.05M
70.64%45.01M
124.07%49.91M
125.30%55.68M
-31.51%20.16M
-30.54%26.38M
146.57%22.27M
235.46%24.71M
209.54%29.44M
Other non current assets
-18.39%24.72M
-34.29%18.95M
-16.69%32.83M
-5.12%28.64M
-1.44%30.3M
-68.06%28.84M
32.84%39.41M
-29.97%30.19M
-32.10%30.74M
286.65%90.27M
Total non current assets
15.39%3B
-2.93%2.62B
-13.98%2.54B
-17.78%2.61B
-16.11%2.6B
7.50%2.7B
29.98%2.95B
45.71%3.18B
52.50%3.09B
20.77%2.51B
Total assets
14.01%6.66B
12.78%6.67B
-8.40%5.77B
-8.05%5.77B
-8.89%5.85B
-10.94%5.92B
29.77%6.3B
33.97%6.27B
32.97%6.42B
48.99%6.64B
Liabilities
Current liabilities
Short term loan
----
----
----
----
----
-98.64%3M
1,094.70%204.36M
1,142.05%219.79M
1,374.35%221.05M
2,116.81%220.13M
Transactional financial liabilities
----
----
-33.27%10.44M
--4.65M
--15.64M
--15.64M
--15.64M
----
----
----
Notes payable and accounts payable
18.21%196.38M
-16.87%179.04M
-59.24%130.46M
-56.16%132.81M
-50.84%166.12M
-65.03%215.38M
-19.98%320.08M
-11.66%302.94M
-8.44%337.93M
66.22%615.94M
-Notes payable
----
----
----
----
----
----
----
--0
----
----
-Accounts payable
18.21%196.38M
-16.87%179.04M
-59.24%130.46M
-56.16%132.81M
-50.84%166.12M
-65.03%215.38M
-19.98%320.08M
-11.66%302.94M
-8.44%337.93M
66.22%615.94M
Contract liabilities
-2.58%60.59M
-10.14%66.9M
-69.16%72.88M
-32.06%64.13M
-41.78%62.19M
-65.16%74.45M
193.38%236.31M
-21.37%94.38M
-45.98%106.81M
106.26%213.71M
Advance receipts
----
----
----
----
----
----
----
--0
----
----
Salaries payable
19.31%115.14M
18.18%86.71M
-8.33%151.05M
-67.09%42.99M
-52.38%96.51M
-44.25%73.37M
20.76%164.77M
160.93%130.64M
129.25%202.65M
71.60%131.6M
Taxs payable
28.66%51.84M
-23.17%52.55M
-56.80%37.37M
-71.91%34.26M
-75.07%40.29M
-60.21%68.39M
228.07%86.5M
237.39%121.98M
120.41%161.64M
176.95%171.89M
Other payable (including interest and dividends)
-20.37%43.23M
-15.21%48.77M
-29.99%61.58M
-55.58%46.88M
-63.33%54.29M
-76.42%57.52M
0.22%87.95M
4.34%105.52M
38.52%148.03M
141.79%243.94M
-Other payable
-20.37%43.23M
----
-29.99%61.58M
----
-63.33%54.29M
----
0.22%87.95M
----
38.52%148.03M
----
Hold and for sell liabilities
----
----
----
----
----
----
----
--0
----
----
Non current liabilities due within one year
-4.18%21.7M
96.51%20.78M
12.73%19.01M
21.76%21.6M
-24.63%22.64M
-66.25%10.57M
-58.63%16.86M
21.34%17.74M
253.14%30.04M
277.87%31.33M
Other current liabilities
44.35%789.63K
-43.47%769.25K
-82.63%1.45M
-8.24%549.94K
-44.34%547.03K
153.88%1.36M
224.80%8.33M
--599.32K
524.54%982.83K
119.08%536.01K
Total current liabilities
6.86%489.66M
-12.35%455.51M
-57.56%484.23M
-64.99%347.88M
-62.10%458.23M
-68.10%519.67M
44.16%1.14B
45.55%993.6M
40.75%1.21B
122.47%1.63B
Current liabilities
Long term loan
----
----
----
----
----
----
----
--0
----
----
Bonds payable
3.82%566.34M
3.82%559.6M
3.82%552.84M
3.81%546.09M
4.34%545.5M
4.40%539.03M
4.27%532.49M
4.30%526.04M
4.56%522.8M
4.22%516.31M
Long term salaries pay
----
----
----
----
----
----
----
--0
----
----
Estimate liabilities
----
----
----
----
----
----
----
--0
----
----
Deferred tax liabilities
-5.00%53.35M
-1.09%53.88M
-1.13%55.12M
17.31%57.67M
14.90%56.16M
87.05%54.47M
87.73%55.75M
130.46%49.16M
227.74%48.88M
141.30%29.12M
Long term deferred income
17.71%48.88M
-7.49%43.35M
61.12%37.21M
55.06%40.93M
12.09%41.52M
10.98%46.86M
145.70%23.1M
111.95%26.4M
188.47%37.05M
15.14%42.22M
Lease liabilities
-2.36%33.69M
229.58%37.14M
147.53%27.69M
428.76%30.04M
799.35%34.51M
19.33%11.27M
7.30%11.19M
-37.11%5.68M
-47.91%3.84M
-0.70%9.44M
Other non current liabilities
----
----
----
----
----
----
----
--0
----
----
Total non current liabilities
3.62%702.26M
6.50%693.97M
8.09%672.87M
11.11%674.73M
10.63%677.7M
9.13%651.62M
11.12%622.53M
10.99%607.27M
12.74%612.56M
5.81%597.1M
Total liabilities
4.93%1.19B
-1.86%1.15B
-34.39%1.16B
-36.12%1.02B
-37.64%1.14B
-47.39%1.17B
30.47%1.76B
30.17%1.6B
29.90%1.82B
71.70%2.23B
Shareholders equity
Paid-in capital
6.13%471.77M
6.18%471.97M
0.00%444.52M
0.00%444.52M
-0.07%444.51M
-0.07%444.51M
-0.10%444.51M
-0.10%444.51M
-0.03%444.83M
29.85%444.83M
Other equity instruments
-0.01%107.49M
-0.01%107.49M
-0.01%107.49M
-0.02%107.49M
-0.01%107.5M
-0.07%107.5M
-0.10%107.5M
0.01%107.51M
-0.00%107.51M
-0.26%107.57M
Capital reserve funds
83.68%1.42B
82.53%1.43B
-1.29%765.52M
-4.82%770.78M
-4.47%770.75M
-1.66%781.82M
-1.46%775.53M
0.61%809.77M
2.92%806.79M
-7.93%795M
Surplus reserve funds
0.00%261.06M
0.00%261.06M
0.00%261.06M
0.00%261.06M
0.00%261.06M
0.00%261.06M
0.00%261.06M
29.68%261.06M
29.68%261.06M
29.68%261.06M
Retained profit
10.65%3.34B
9.06%3.39B
9.18%3.17B
4.63%3.08B
4.62%3.02B
13.29%3.11B
57.85%2.9B
55.74%2.95B
58.45%2.89B
72.40%2.74B
Less:Treasury stock
3.75%118.21M
-15.79%132.46M
-15.79%132.46M
13.75%144.04M
-15.73%113.95M
15.54%157.3M
12.96%157.3M
-17.66%126.63M
28.64%135.21M
25.78%136.14M
Other composite income
-1,128.27%-100.86M
-1,320.94%-101.18M
-1,386.69%-101.59M
-83.81%10.11M
-82.51%9.81M
-84.52%8.29M
-84.69%7.9M
299.11%62.46M
262.73%56.09M
221.39%53.54M
Ordinary risk reserve funds
----
----
----
----
----
----
----
--0
----
----
Specific reserves
----
----
----
----
----
----
----
--0
----
----
Shareholders equity without minority interests
19.54%5.38B
19.09%5.42B
3.96%4.52B
0.62%4.53B
1.62%4.5B
6.67%4.55B
29.55%4.34B
36.01%4.51B
35.41%4.43B
41.61%4.27B
Minority interests
-54.95%95.05M
-47.61%100.77M
-49.09%98.66M
27.64%210.78M
25.87%210.98M
28.93%192.34M
28.37%193.8M
18.91%165.14M
9.16%167.62M
0.56%149.17M
Total shareholder equity
16.20%5.47B
16.39%5.52B
1.69%4.61B
1.57%4.74B
2.51%4.71B
7.42%4.75B
29.50%4.54B
35.32%4.67B
34.23%4.59B
39.68%4.42B
Total liabilityies and equity
14.01%6.66B
12.78%6.67B
-8.40%5.77B
-8.05%5.77B
-8.89%5.85B
-10.94%5.92B
29.77%6.3B
33.97%6.27B
32.97%6.42B
48.99%6.64B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds -62.27%393.56M56.27%1.17B-27.72%840.3M226.30%732.82M79.15%1.04B27.88%749M16.70%1.16B-75.46%224.58M-39.37%582.19M-37.95%585.7M
Transactional financial assets 35.92%1.45B-21.28%1.01B-22.99%722.45M-9.30%1.35B-19.33%1.06B150.56%1.28B63.79%938.07M269.66%1.49B109.12%1.32B36.54%512.32M
Notes receivable and accounts receivable 40.50%826.87M31.36%744.11M10.89%599.87M-10.82%568.8M-7.21%588.51M-72.47%566.47M7.81%540.97M18.74%637.79M22.11%634.26M417.21%2.06B
-Notes receivable -86.55%391.16K-90.32%195.22K104.93%1.65M-65.86%1.52M-64.59%2.91M48.38%2.02M-76.71%806.42K-5.69%4.44M37.67%8.21M79.14%1.36M
-Accounts receivable 41.13%826.48M31.79%743.92M10.75%598.22M-10.43%567.28M-6.46%585.6M-72.55%564.45M8.40%540.16M18.96%633.35M21.93%626.05M417.86%2.06B
Other receivables (including interest and dividends) -10.11%70.67M-31.77%58.76M-22.35%51.72M-30.45%75.28M-1.46%78.62M3.85%86.12M2.95%66.6M-1.57%108.23M-24.98%79.79M18.74%82.93M
-Other receivable -10.11%70.67M-----22.35%51.72M-----1.46%78.62M----2.95%66.6M-----24.98%79.79M----
Contractual assets ------------------------------0--------
Advance payment -34.38%21.36M-33.97%26.11M-35.01%17.26M-45.89%27.87M-55.64%32.54M-68.92%39.55M-50.40%26.56M-13.65%51.5M1.99%73.37M153.22%127.22M
Inventories -0.80%412.39M-25.67%346.89M-12.14%351.4M-33.58%381.74M-33.44%415.73M-38.46%466.71M3.55%399.97M23.04%574.7M25.44%624.62M74.24%758.37M
Receivable financing ------------------------------0--------
Assets held for sale ------------------------------0--------
Non-current assets due within one year --------------------------200.26M--0--------
Other current assets 1,812.90%496.33M2,868.37%693.45M4,110.41%650.34M81.39%18.85M266.22%25.95M277.53%23.36M49.12%15.45M-0.34%10.39M-17.16%7.08M-94.15%6.19M
Total current assets 12.90%3.67B25.99%4.05B-3.49%3.23B1.93%3.16B-2.17%3.25B-22.17%3.21B29.58%3.35B23.74%3.1B18.79%3.32B73.69%4.13B
Non Current assets
Debt investment 171.28%569.22M-47.76%215.91M-70.31%213.94M-76.81%211.87M-76.85%209.83M-0.07%413.34M75.01%720.48M123.00%913.6M122.35%906.51M-26.02%413.63M
Other debt investment ------------------------------0--------
Other equity investment -56.19%89.18M-55.54%89.18M-55.46%89.18M-10.16%203.07M-9.94%203.57M-11.27%200.57M-11.42%200.22M20.42%226.04M20.42%226.04M20.42%226.04M
Other non-current financial assets ------------------------------0--------
Investment real estate ------------------------------0--------
Long-term equity investment 14.41%449.48M25.05%453.62M11.79%406.36M12.65%391.34M15.90%392.88M9.08%362.74M8.94%363.52M2.24%347.39M13.82%338.98M18.00%332.54M
Long term receivable account ------------------------------0--------
Fixed assets 2.28%999.66M----5.50%1.02B----1.87%977.33M----13.16%963.8M----72.84%959.38M----
Constru in process 21.22%359.74M----46.05%290.84M----221.59%296.76M----1,116.01%199.14M-----52.31%92.28M----
Productive biological assets ------------------------------0--------
Oil and gas assets ------------------------------0--------
Intangible assets -3.66%190.72M-6.43%188.32M-4.51%194.52M-15.99%190.87M-15.59%197.96M-20.21%201.26M-2.11%203.71M26.24%227.21M28.99%234.52M44.75%252.25M
Development expenditure 31.39%70.37M31.37%65.65M28.94%66.74M25.31%69.75M-2.32%53.55M-8.53%49.98M-4.31%51.76M-35.69%55.66M-14.75%54.83M-4.67%54.64M
Goodwill -3.43%111.42M-3.43%111.42M-3.43%111.42M-27.23%115.37M-27.23%115.37M-5.21%115.37M171.38%115.37M227.66%158.54M227.66%158.54M151.53%121.71M
Long deferred expense 27.79%17.02M51.81%18.23M0.12%13.29M-20.76%12.44M-14.22%13.32M-38.38%12.01M-15.23%13.28M-0.93%15.7M7.90%15.53M33.42%19.48M
Deferred tax assets 25.81%62.61M4.06%59.93M6.71%57.47M-0.84%50.48M-5.84%49.77M-5.40%57.59M25.93%53.86M19.85%50.91M102.55%52.85M100.76%60.88M
Usufruct assets -6.85%51.86M177.98%56.05M70.64%45.01M124.07%49.91M125.30%55.68M-31.51%20.16M-30.54%26.38M146.57%22.27M235.46%24.71M209.54%29.44M
Other non current assets -18.39%24.72M-34.29%18.95M-16.69%32.83M-5.12%28.64M-1.44%30.3M-68.06%28.84M32.84%39.41M-29.97%30.19M-32.10%30.74M286.65%90.27M
Total non current assets 15.39%3B-2.93%2.62B-13.98%2.54B-17.78%2.61B-16.11%2.6B7.50%2.7B29.98%2.95B45.71%3.18B52.50%3.09B20.77%2.51B
Total assets 14.01%6.66B12.78%6.67B-8.40%5.77B-8.05%5.77B-8.89%5.85B-10.94%5.92B29.77%6.3B33.97%6.27B32.97%6.42B48.99%6.64B
Liabilities
Current liabilities
Short term loan ---------------------98.64%3M1,094.70%204.36M1,142.05%219.79M1,374.35%221.05M2,116.81%220.13M
Transactional financial liabilities ---------33.27%10.44M--4.65M--15.64M--15.64M--15.64M------------
Notes payable and accounts payable 18.21%196.38M-16.87%179.04M-59.24%130.46M-56.16%132.81M-50.84%166.12M-65.03%215.38M-19.98%320.08M-11.66%302.94M-8.44%337.93M66.22%615.94M
-Notes payable ------------------------------0--------
-Accounts payable 18.21%196.38M-16.87%179.04M-59.24%130.46M-56.16%132.81M-50.84%166.12M-65.03%215.38M-19.98%320.08M-11.66%302.94M-8.44%337.93M66.22%615.94M
Contract liabilities -2.58%60.59M-10.14%66.9M-69.16%72.88M-32.06%64.13M-41.78%62.19M-65.16%74.45M193.38%236.31M-21.37%94.38M-45.98%106.81M106.26%213.71M
Advance receipts ------------------------------0--------
Salaries payable 19.31%115.14M18.18%86.71M-8.33%151.05M-67.09%42.99M-52.38%96.51M-44.25%73.37M20.76%164.77M160.93%130.64M129.25%202.65M71.60%131.6M
Taxs payable 28.66%51.84M-23.17%52.55M-56.80%37.37M-71.91%34.26M-75.07%40.29M-60.21%68.39M228.07%86.5M237.39%121.98M120.41%161.64M176.95%171.89M
Other payable (including interest and dividends) -20.37%43.23M-15.21%48.77M-29.99%61.58M-55.58%46.88M-63.33%54.29M-76.42%57.52M0.22%87.95M4.34%105.52M38.52%148.03M141.79%243.94M
-Other payable -20.37%43.23M-----29.99%61.58M-----63.33%54.29M----0.22%87.95M----38.52%148.03M----
Hold and for sell liabilities ------------------------------0--------
Non current liabilities due within one year -4.18%21.7M96.51%20.78M12.73%19.01M21.76%21.6M-24.63%22.64M-66.25%10.57M-58.63%16.86M21.34%17.74M253.14%30.04M277.87%31.33M
Other current liabilities 44.35%789.63K-43.47%769.25K-82.63%1.45M-8.24%549.94K-44.34%547.03K153.88%1.36M224.80%8.33M--599.32K524.54%982.83K119.08%536.01K
Total current liabilities 6.86%489.66M-12.35%455.51M-57.56%484.23M-64.99%347.88M-62.10%458.23M-68.10%519.67M44.16%1.14B45.55%993.6M40.75%1.21B122.47%1.63B
Current liabilities
Long term loan ------------------------------0--------
Bonds payable 3.82%566.34M3.82%559.6M3.82%552.84M3.81%546.09M4.34%545.5M4.40%539.03M4.27%532.49M4.30%526.04M4.56%522.8M4.22%516.31M
Long term salaries pay ------------------------------0--------
Estimate liabilities ------------------------------0--------
Deferred tax liabilities -5.00%53.35M-1.09%53.88M-1.13%55.12M17.31%57.67M14.90%56.16M87.05%54.47M87.73%55.75M130.46%49.16M227.74%48.88M141.30%29.12M
Long term deferred income 17.71%48.88M-7.49%43.35M61.12%37.21M55.06%40.93M12.09%41.52M10.98%46.86M145.70%23.1M111.95%26.4M188.47%37.05M15.14%42.22M
Lease liabilities -2.36%33.69M229.58%37.14M147.53%27.69M428.76%30.04M799.35%34.51M19.33%11.27M7.30%11.19M-37.11%5.68M-47.91%3.84M-0.70%9.44M
Other non current liabilities ------------------------------0--------
Total non current liabilities 3.62%702.26M6.50%693.97M8.09%672.87M11.11%674.73M10.63%677.7M9.13%651.62M11.12%622.53M10.99%607.27M12.74%612.56M5.81%597.1M
Total liabilities 4.93%1.19B-1.86%1.15B-34.39%1.16B-36.12%1.02B-37.64%1.14B-47.39%1.17B30.47%1.76B30.17%1.6B29.90%1.82B71.70%2.23B
Shareholders equity
Paid-in capital 6.13%471.77M6.18%471.97M0.00%444.52M0.00%444.52M-0.07%444.51M-0.07%444.51M-0.10%444.51M-0.10%444.51M-0.03%444.83M29.85%444.83M
Other equity instruments -0.01%107.49M-0.01%107.49M-0.01%107.49M-0.02%107.49M-0.01%107.5M-0.07%107.5M-0.10%107.5M0.01%107.51M-0.00%107.51M-0.26%107.57M
Capital reserve funds 83.68%1.42B82.53%1.43B-1.29%765.52M-4.82%770.78M-4.47%770.75M-1.66%781.82M-1.46%775.53M0.61%809.77M2.92%806.79M-7.93%795M
Surplus reserve funds 0.00%261.06M0.00%261.06M0.00%261.06M0.00%261.06M0.00%261.06M0.00%261.06M0.00%261.06M29.68%261.06M29.68%261.06M29.68%261.06M
Retained profit 10.65%3.34B9.06%3.39B9.18%3.17B4.63%3.08B4.62%3.02B13.29%3.11B57.85%2.9B55.74%2.95B58.45%2.89B72.40%2.74B
Less:Treasury stock 3.75%118.21M-15.79%132.46M-15.79%132.46M13.75%144.04M-15.73%113.95M15.54%157.3M12.96%157.3M-17.66%126.63M28.64%135.21M25.78%136.14M
Other composite income -1,128.27%-100.86M-1,320.94%-101.18M-1,386.69%-101.59M-83.81%10.11M-82.51%9.81M-84.52%8.29M-84.69%7.9M299.11%62.46M262.73%56.09M221.39%53.54M
Ordinary risk reserve funds ------------------------------0--------
Specific reserves ------------------------------0--------
Shareholders equity without minority interests 19.54%5.38B19.09%5.42B3.96%4.52B0.62%4.53B1.62%4.5B6.67%4.55B29.55%4.34B36.01%4.51B35.41%4.43B41.61%4.27B
Minority interests -54.95%95.05M-47.61%100.77M-49.09%98.66M27.64%210.78M25.87%210.98M28.93%192.34M28.37%193.8M18.91%165.14M9.16%167.62M0.56%149.17M
Total shareholder equity 16.20%5.47B16.39%5.52B1.69%4.61B1.57%4.74B2.51%4.71B7.42%4.75B29.50%4.54B35.32%4.67B34.23%4.59B39.68%4.42B
Total liabilityies and equity 14.01%6.66B12.78%6.67B-8.40%5.77B-8.05%5.77B-8.89%5.85B-10.94%5.92B29.77%6.3B33.97%6.27B32.97%6.42B48.99%6.64B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data